Synonyms: | |
Status: | Approved (2007) |
Entry Type: | Small molecule |
Molecule Category: | Parent |
ATC: | C07AB12 |
UNII: | 030Y90569U |
InChI Key | KOHIRBRYDXPAMZ-UHFFFAOYSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C22H25F2NO4 |
Molecular Weight | 405.44 |
AlogP | 2.36 |
Hydrogen Bond Acceptor | 5.0 |
Hydrogen Bond Donor | 3.0 |
Number of Rotational Bond | 6.0 |
Polar Surface Area | 70.95 |
Molecular species | BASE |
Aromatic Rings | 2.0 |
Heavy Atoms | 29.0 |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Auxiliary transport protein
Slow voltage-gated potassium channel accessory protein family
|
- | 15849-39811 | - | - | - | |
Ion channel
Voltage-gated ion channel
Potassium channels
Voltage-gated potassium channel
|
- | 316-6310 | - | - | - | |
Ion channel
Voltage-gated ion channel
Voltage-gated calcium channel
|
- | 15849 | - | - | - | |
Ion channel
Voltage-gated ion channel
Voltage-gated sodium channel
|
- | 6310-7943 | - | - | - |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Hypertension | 3 | D006973 | ClinicalTrials |
Marfan Syndrome | 3 | D008382 | ClinicalTrials |
Severe Acute Respiratory Syndrome | 3 | D045169 | ClinicalTrials |
Essential Hypertension | 2 | D000075222 | ClinicalTrials |
Stroke | 2 | D020521 | ClinicalTrials |
Idiopathic Pulmonary Fibrosis | 1 | D054990 | ClinicalTrials |
Osteoporosis | 0 | D010024 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 118457-14-0 |
ChEBI | 64019 |
ChEMBL | CHEMBL434394 |
DrugBank | DB04861 |
DrugCentral | 1887 |
EPA CompTox | DTXSID9040556 |
FDA SRS | 030Y90569U |
Human Metabolome Database | HMDB0015594 |
Guide to Pharmacology | 7246 |
PharmGKB | PA151958426 |
SureChEMBL | SCHEMBL19863 |